Home LiteratureArticle Details
PMID: 12483522 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

GADD45-induced cell cycle G2-M arrest associates with altered subcellular distribution of cyclin B1 and is independent of p38 kinase activity.

Oncogene ·Vol. 21 ·No. 57 ·2002-12-12 ·Pages 8696-704

Jin S, Tong T, Fan W, Fan F, Antinore MJ, Zhu X, Mazzacurati L, Li X, Petrik KL, Rajasekaran B, Wu M, Zhan Q

Abstract

In response to DNA damage, the cell cycle checkpoint is an important biological event in maintaining genomic fidelity. Gadd45, a p53-regulated and DNA damage inducible protein, has recently been demonstrated to play a role in the G2-M checkpoint in response to DNA damage. In the current study, we further investigated the biochemical mechanism(s) involved in the GADD45-activated cell cycle G2-M arrest. Using the tetracycline-controlled system (tet-off), we established GADD45-inducible lines in HCT116 (wild-type p53) and Hela (inactivated p53 status) cells. Following inducible expression of the Gadd45 protein, cell growth was strongly suppressed in both HCT116 and Hela cells. Interestingly, HCT116 cells revealed a significant G2-M arrest but Hela cells failed to arrest at the G2-M phases, indicating that the GADD45-activated G2-M arrest requires normal p53 function. The GADD45-induced G2-M arrest was observed independent of p38 kinase activity. Importantly, induction of Gadd45 protein resulted in a reduction of nuclear cyclin B1 protein, whose nuclear localization is critical for the completion of G2-M transition. The reduced nuclear cyclin B1 levels correlated with inhibition of Cdc2/cyclin B1 kinase activity. Additionally, overexpression of cyclin B1 substantially abrogated the GADD45-induced cell growth suppression. Therefore, GADD45 inhibition of Cdc2 kinase activity through alteration of cyclin B1 subcellular localization may be an essential step in the GADD45-induced cell cycle G2-M arrest and growth suppression.

MeSH Terms
Checkpoint Kinase 1 Cyclin B/metabolism Cyclin B1 G2 Phase/genetics HeLa Cells Humans Intracellular Signaling Peptides and Proteins Mitogen-Activated Protein Kinases/metabolism Mitosis/genetics Phosphorylation Protein Kinases/metabolism Proteins/genetics Subcellular Fractions/metabolism Tumor Cells, Cultured Tumor Suppressor Protein p53/physiology p38 Mitogen-Activated Protein Kinases
Chemicals
CCNB1 protein, human Cyclin B Cyclin B1 GADD45 protein Intracellular Signaling Peptides and Proteins Proteins Tumor Suppressor Protein p53 Protein Kinases Checkpoint Kinase 1 Mitogen-Activated Protein Kinases p38 Mitogen-Activated Protein Kinases
Authors & Affiliations
12 authors, click to expand affiliations / ORCID
Jin Shunqian
Department of Radiation Oncology, Cancer Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, PA 15213, USA.
Tong Tong
Fan Wenhong
Fan Feiyue
Antinore Michael J
Zhu Xiaocheng
Mazzacurati Lucia
Li Xianxing
Petrik Kimberly L
Rajasekaran Baskaran
Wu Min
Zhan Qimin
Article Info
Journal
Oncogene
Abbr.
Oncogene
ISSN
0950-9232
Published
2002-12-12
Pages
8696-704
Language
English
Region
England
NLM ID
8711562
Subset
IM
Grants
NCI NIH HHS · R01 CA-83874 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com